EVAXION a/S

Evaxion Biotech stock falls 8.4% to $3.76, but a 13.5% monthly rise and a healthy 200‑day average suggest a potential recovery and future growth.

Evaxion Biotech (EVAX) fell 8.4% on Nov 22, 2026, trading at $3.71 with a $33.5M market cap, amid a 13.46% YTD gain and strong 200‑day support.

Evaxion Biotech sees 21.6% surge in 24‑hour trading—market cap hits $27.8M, share price at $4.05. Explore its rapid growth, 52‑week highs, and peer performance.

Evaxion Biotech surges 17.7% on strong biotech demand—$4.05 share, $23.6 M cap, promising pipeline, Nasdaq listing. Explore why investors love it.